Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Interstitial lung disease Stories

2011-12-06 15:48:00

CHICAGO, Dec. 6, 2011 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation's (PFF) inaugural conference on idiopathic pulmonary fibrosis (IPF), IPF Summit 2011: From Bench to Bedside, was recently held in Chicago. The event brought together medical professionals, patients, and caregivers for an innovative two-day meeting. Gregory P. Cosgrove, MD, IPF Summit 2011 Faculty Member and PFF Medical Advisory Board Member commented on the importance of the event: "The Summit...

2011-12-02 01:37:00

Tracking individual cells within the lungs as they move around and multiply has given Duke University researchers new insights into the causes of Idiopathic Pulmonary Fibrosis (IPF) a disease which can only be treated now by lung transplantation. IPF fills the delicate gas exchange region of the lung with scar tissue, progressively restricting breathing. The Duke University Medical Center researchers have discovered that some commonly held ideas about the origins of the scar-forming...

2011-10-31 15:00:00

BRISBANE, Calif., Oct. 31, 2011 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that Angus C. Russell, Chief Executive Officer of Shire plc, has been appointed to InterMune's Board of Directors. Shire is a leading global biopharmaceutical company focused on meeting the needs of the specialist physician. "Angus Russell has successfully led Shire's evolution to a leading global biopharmaceutical company with expertise in the development and commercialization of specialty...

2011-10-27 21:59:20

Guided by insights into how mice recover after H1N1 flu, researchers at Harvard Medical School and Brigham and Women's Hospital, together with researchers at A*STAR of Singapore, have cloned three distinct stem cells from the human airways and demonstrated that one of these cells can form into the lung's alveoli air sac tissue. What's more, the researchers showed that these same lung stem cells are rapidly deployed in a dynamic process of lung regeneration to combat damage from infection or...

2011-10-27 07:00:00

BRISBANE, Calif., Oct. 27, 2011 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that it will release its third quarter 2011 financial results at the close of the U.S. markets on Thursday, November 3, 2011. A live conference call and webcast will be hosted by InterMune at 4:30 p.m. Eastern time that same day. Interested investors and others may participate in the conference call by dialing 888-567-5125 (U.S.) or 706-643-9223 (international), conference ID# 22885421. A...

2011-10-26 00:36:36

A panel of blood proteins can predict which patients with the progressive lung disease idiopathic pulmonary fibrosis (IPF) are likely to live at least five years or to die within two years, say researchers at the University of Pittsburgh School of Medicine and Centocor R&D. The findings, published online last week in the American Journal of Respiratory and Critical Care Medicine, could help doctors determine those patients in imminent need of a lung transplant and those who can wait a...

2011-10-24 09:10:05

NIH stops one treatment arm of trial; Other two treatments to continue The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has stopped one arm of a three arm multi-center, clinical trial studying treatments for the lung-scarring disease idiopathic pulmonary fibrosis (IPF) for safety concerns. The trial found that people with IPF receiving a currently used triple-drug therapy consisting of prednisone, azathioprine, and N-acetylcysteine (NAC) had...

2011-10-17 16:37:00

New Awards Totaling $200,000 to be Offered in 2012; Deadline for Letters of Intent is November 17, 2011 CHICAGO, Oct. 17, 2011 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) announced today that it has established the PFF Research Fund to Cure Pulmonary Fibrosis, a fund created to support research that will assist in the development of successful therapies for pulmonary fibrosis (PF). PF is a progressive and ultimately fatal lung disease that affects more than 200,000...

2011-10-11 08:30:00

The First Annual Linda Biggs 5K Walk/Run, Quest for Cure is Saturday, October 15th LEXINGTON, S.C., Oct. 11, 2011 /PRNewswire-USNewswire/ -- A S.C. woman is holding a 5K in Lexington to raise awareness of lung disease that claimed her mother-in-law's life just a couple of years ago. Kathy Biggs, a licensed physician therapist, saw her mother-in-law suffer from Pulmonary Fibrosis (PF), a disease that scars the lungs and suffocates its victims. There was nothing even she, a medical...

2011-10-06 09:18:01

Study points to a phosphorylation pathway that may contribute to the development of lung injury and fibrosis A study by researchers at the University of California, San Diego School of Medicine may lead to a way to prevent the progression, or induce the regression, of lung injury that results from use of the anti-cancer chemotherapy drug Bleomycin. Pulmonary fibrosis caused by this drug, as well as Idiopathic Pulmonary Fibrosis (IPF) from unknown causes, affect nearly five million people...